Janus Henderson Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Janus Henderson Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-92,172	Closed	-$3.89M	–	875
2015 Q2	$3.89M	Sell	92,172 -197,654	-68%	-$8.34M	0.03%	392
2015 Q1	$11.2M	Sell	289,826 -115,174	-28%	-$4.44M	0.09%	262
2014 Q4	$13.6M	Buy	405,000 +351,004	+650%	+$12.4M	0.1%	243
2014 Q3	$1.89M	Buy	+53,996	New	+$1.85M	0.02%	439
2013 Q3	–	Sell	-182,713	Closed	-$3.88M	–	786
2013 Q2	$3.88M	Buy	+182,713	New	+$3.57M	0.05%	285

Other funds holding WX

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Janus Henderson Group's WX Position: Q3 2015 in Review

Janus Henderson Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 92,172 shares — an estimated $3.89M sold.

Janus Henderson Group first reported a position in WX in Q2 2013 and held it in 5 quarters. The position peaked at $13.6M in Q4 2014. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

Janus Henderson Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
Janus Henderson Group sold 92,172 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $3.89M.
Janus Henderson Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 5 quarters.
Janus Henderson Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $13.6M in Q4 2014.
151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Janus Henderson Group's 13F filing for Q3 2015, filed 16 Nov 2015.